4-Cbz-Aminopiperidine Chemical Properties

Boiling point:

396.3±41.0 °C(Predicted)

Density 

1.13±0.1 g/cm3(Predicted)

storage temp. 

under inert gas (nitrogen or Argon) at 2–8 °C

solubility 

Dichloromethane

form 

Solid

pka

12.18±0.20(Predicted)

color 

White

InChI

InChI=1S/C13H18N2O2/c16-13(15-12-6-8-14-9-7-12)17-10-11-4-2-1-3-5-11/h1-5,12,14H,6-10H2,(H,15,16)

InChIKey

WWGUAFRTAYMNHU-UHFFFAOYSA-N

SMILES

C(OCC1=CC=CC=C1)(=O)NC1CCNCC1

Safety Information

Safety Statements 

24/25

HS Code 

29333990

4-Cbz-Aminopiperidine Usage And Synthesis

Uses

4-Benzyloxycarbonylaminopiperidine is an intermediate in synthesizing 7-Ethyl-10-(4-amino-1-piperidino)carbonyloxycamptothecin (E899150), a major metabolite of Irinotecan.

Definition

ChEBI: Benzyl 4-piperidinylcarbamate is a member of piperidines.

Synthesis

The general procedure for the synthesis of 4-(N-benzyloxycarbonyl)-aminopiperidine from 1-Boc-4-(Cbz-amino)piperidine was as follows: tert-butyl 4-{[(benzyloxy)carbonyl]amino}piperidine-1-carboxylate (13.1 g, 39.2 mmol) obtained in Example 1a was mixed with a 5N aqueous hydrochloric acid (40 ml, 200 mmol) and a methanolic (40 ml) The mixture was stirred at room temperature for 23 hours. After completion of the reaction, 5N aqueous sodium hydroxide solution (40 ml) was slowly added to the reaction mixture under ice bath cooling conditions. Subsequently, water and solvent were removed from the reaction mixture by distillation while azeotropic distillation using ethanol was carried out to remove water completely. Ethanol was added to the distilled residue, filtered to remove insoluble matter, and the filtrate was concentrated to give the final 4-(N-benzyloxycarbonyl)-aminopiperidine (9.10 g, 99.1% yield). The product was characterized by 1H-NMR (400 MHz, CDCl3) with the following chemical shifts δppm: 1.31-1.42 (2H, m), 1.92-2.04 (2H, br), 2.70 (2H, d, J = 12Hz), 3.10 (2H, d, J = 12Hz), 3.56-3.68 (1H, br), 4.72- 4.81 (1H, br), 5.09 (2H, s), 7.26-7.40 (5H, m).

References

[1] Patent: US2013/65925, 2013, A1. Location in patent: Paragraph 0197; 0198
[2] Patent: EP2757103, 2014, A1. Location in patent: Paragraph 0149
[3] Journal of Medicinal Chemistry, 2012, vol. 55, # 3, p. 1021 - 1046
[4] Patent: WO2011/60321, 2011, A1. Location in patent: Page/Page column 115
[5] Patent: WO2006/99884, 2006, A1. Location in patent: Page/Page column 18

4-Cbz-Aminopiperidine(182223-54-7)Related Product Information

• Haloperidol
• Benzyl chloroformate
• 1-Aminopiperidine
• Trimethoprim
• Benzyl carbamate
• Benzyloxyacetyl chloride
• Nequinate
• 1-BOC-4-CBZ-AMINO-PIPERIDINE
• 1-Piperidinecarboxylic acid, 3-[[(phenylmethoxy)carbonyl]amino]-, 1,1-dimethylethyl ester, (3R)-
• Piperidine
• 3-CBZ-AMINOPIPERIDINE,3-CBZ-AMINOPIPERIDINE HCL,3-N-Cbz-aminopiperidine hydrochloride
• 1-BOC-4-N-CBZ-AMINOPIPERIDINE-4-CARBOXYLIC ACID
• 4-BENZYLOXY-CARBONYL-AMINO-1-N-BUTOXY-CARBONYL-4-METHYL PIPERIDINE
• METHYL-(1-METHYL-4-PYRROLIDIN-1-YLMETHYL-PIPERIDIN-4-YL)-CARBAMIC ACID BENZYL ESTER
• L371,257
• 4-BENZYLOXYCARBONYLAMINO-4-METHYL-PIPERIDINE
• 4-Cbz-Aminopiperidine
• (4r,5s)-4-methyl-5-phenyl-3-piperidin-4-yl-1,3-oxazolidin-2-one hydrochloride